Press release
Active Pharmaceutical Ingredients Market Pegged to Rise at 7.2% CAGR by 2023
Market Research Future adds new report of “Active Pharmaceutical Ingredients Market Research Report - Global Forecast to 2023” it contains Company information, geographical data and Table of ContentMarket Highlight:
Active Pharmaceutical Ingredient (API) is a biologically active pharmaceutical drug. API can be obtain by synthetic process or from natural sources. The global active pharmaceutical ingredients market is driven by increasing prevalence of chronic diseases, rising cancer population and adoption of the biologic and natural therapy by the people. According to WHO, approximately 14 million new cases was registered in 2012 and is expected to rise to almost 19 million by 2024. The number is increasing continuously due to increasing consumption of alcohol, poor lifestyle. Beside this technological development, increasing demand for the new and better treatment and increasing aging population are some other factors driving the growth of the market. Increasing demand for the generic drugs in developing countries like India and China has increased the demand development of new active ingredients. This two countries account nearly 80% of total generic drug sale. Stringent regulatory requirements and lack of awareness in majority of people may restrains the growth of the market. Global active pharmaceutical ingredients market is expected to grow at a CAGR of 7.2% during forecasted period.
Market Segmentation:
Global active pharmaceutical ingredients market is segmented;
• By Manufacturing Process; Captive manufacturing, contract manufacturing
• By Source synthetic and biological
• By Type generic, branded
• By Application
Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/1385
Competitive Analysis:
• Teva Pharmaceutical Industries (Israel)
• Cipla (India)
• Dr. Reddy’s Laboratories (India)
• Novartis International AG (Switzerland)
• Sanofi (France)
• Pfizer Inc. (US)
• Eli Lilly and Company (US)
• Aurobindo Pharma (US)
• Sun Pharmaceutical Industries (India)
• Boehringer Ingelheim (Germany)
• Bristol-Myers Squibb (US)
• GlaxoSmithKline Plc. (UK)
• Merck & Co. Inc. (US)
• AbbVie Inc. (US).
Intended Audience
• Research and Development (R&D) Companies
• API manufacturing company
• Government and Independent Research Laboratories
• Government and Independent Regulatory Authorities
• Contract Research Organizations (CROs)
• Medical Research Laboratories
• Academic Medical Institutes and Universities
Browse Report Details @ https://www.marketresearchfuture.com/reports/active-pharmaceutical-ingredients-market
Table of Contents
1 Introduction
1.1 Definition
1.2 Scope Of Study
1.2.1 Research Objective
1.2.2 Assumptions & Limitations
1.2.2.1 Assumptions
1.2.2.2 Limitations
1.3 Market Structure:
2 Research Methodology
2.1 Research Process:
2.2 Primary Research
2.3 Secondary Research:
3 Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Macroeconomic Indicators
4 Market Factor Analysis
4.1 Porters Five Forces Model
4.2 Bargaining Power Of Suppliers
4.3 Bargaining Power Of Buyers
4.4 Threat Of New Entrants
4.5 Threat Of Substitutes
4.6 Intensity Of Rivalry
5. Global Active Pharmaceutical Ingredients Market, By Manufacturing Process
5.1 Captive Manufacturing
5.2 Contract Manufacturing
6. Global Active Pharmaceutical Ingredients Market, By Source
6.1 Synthetic
6.2 Biological
7. Global Active Pharmaceutical Ingredients Market, By Type
7.1 Generic
7.2 Branded
8. Global Active Pharmaceutical Ingredients Market, By Application
Continued….
Enquire about this Report @ https://www.marketresearchfuture.com/enquiry/1385
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Contact:
Akash Anand,
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: akash.anand@marketresearchfuture.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Active Pharmaceutical Ingredients Market Pegged to Rise at 7.2% CAGR by 2023 here
News-ID: 703853 • Views: …
More Releases from Market Research Future
Lycopene Industry Growth from USD 0.166 Billion in 2025 to USD 0.2756 Billion by …
The global Lycopene Market is experiencing robust growth, fueled by a powerful wave of health consciousness and a decisive consumer shift towards natural ingredients. Known for its potent antioxidant properties and vibrant red color, lycopene-a carotenoid found abundantly in tomatoes and other red fruits-is becoming a star ingredient in dietary supplements, functional foods, and even cosmetics. According to a comprehensive report by Market Research Future, the market is projected to…
Cosmetic Antioxidants Market to Reach USD 284.82 Billion by 2035 from USD 143.92 …
The global Cosmetic Antioxidants Market is experiencing a remarkable surge, fundamentally reshaping the beauty and personal care industry. This growth is driven by a powerful shift in consumer consciousness toward proactive skin health and an insatiable demand for multifunctional, protective beauty products. According to a comprehensive report by Market Research Future, the market is projected to grow from an estimated USD 153.13 billion in 2025 to USD 284.82 billion by…
Anticoagulation Market To Reach USD 28.51 Billion By 2035 Driven By Rising Cardi …
The global healthcare industry continues to witness increasing demand for therapies that prevent and manage life-threatening conditions, particularly cardiovascular diseases. Among these, anticoagulation therapies play a critical role in preventing blood clot formation, reducing the risk of stroke, deep vein thrombosis, pulmonary embolism, and other serious complications. As cardiovascular disorders remain one of the leading causes of mortality worldwide, the Anticoagulation Market is experiencing consistent growth supported by rising disease…
Antibody Drug Discovery Market To Reach USD 17.28 Billion By 2035 Driven By Risi …
The global biopharmaceutical industry is undergoing a transformative phase, with antibody-based therapies emerging as one of the most promising approaches for treating complex and chronic diseases. Antibody drug discovery has become a cornerstone of modern pharmaceutical research, enabling highly targeted treatments with improved safety and effectiveness. As a result, the Antibody Drug Discovery Market is witnessing significant growth fueled by technological innovation, rising disease prevalence, and increasing investment in biologics.
According…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
